Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02758496 · ClinicalTrials.gov registry record
A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD
A clinical trial of Autistic Disorder, sponsored by Wave Neuroscience.
- Completed
- Registry status
- 141
- Enrollment target
- 1
- Study location
NCT02758496: Completed study of Autistic Disorder, sponsored by Wave Neuroscience.
NCT02758496 is a study of Autistic Disorder that has completed, run by Wave Neuroscience. The registered enrollment target is 141 participants, above the 108-participant average among 27 other Autistic Disorder trials with a reported enrollment target (31% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02758496, a study of Autistic Disorder, has completed, sponsored by Wave Neuroscience.
- COMPLETED
- Registry status
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety and efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).
Primary Outcome
Symptom reduction in ASD will be measured using the reduction in the CARS between two time points: Baseline (BL) CARS and Final CARS Evaluation.
Conditions Studied
Interventions
- OTHER MeRT Efficacy Chart Review
Study Locations (1)
California
- Brain Treatment Center - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-04 |
What the finished NCT02758496 record still lists
NCT02758496 is an observational study that tracks outcomes without assigning an intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, above the 108-participant average among 27 other Autistic Disorder trials with a reported enrollment target (31% higher).
The record links to 1 condition, with Autistic Disorder appearing as the primary indexed condition, and to 1 intervention - of which MeRT Efficacy Chart Review is the first listed.
NCT02758496 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02758496 about?
NCT02758496 is a clinical study titled "A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD". The purpose of this study is to evaluate the safety and efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).
What is the current status of trial NCT02758496?
This trial is currently completed. The enrollment target is 141 participants. The study started on 2016-04. Estimated completion is 2017-04.
What conditions does trial NCT02758496 study?
This clinical trial studies the following conditions: Autistic Disorder.
What interventions are being tested in trial NCT02758496?
The interventions under investigation include: MeRT Efficacy Chart Review (OTHER).
Who is sponsoring clinical trial NCT02758496?
This trial is sponsored by Wave Neuroscience, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02758496 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autistic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02758496's enrollment target sits among peer trials
141 9th of 27 higher than 19 of 27 other Autistic Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autistic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)
RECRUITING · NA
-
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
RECRUITING · NA
-
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
RECRUITING · NA
-
Project AFECT (Autism Family Empowerment Coaching and Training Program)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia